Europe · Agences & temps réel · ANP

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

Publié par ANP · Pays-Bas il y a 18 h

- LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to…

Lire l'article complet sur ANP Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (persportaal.anp.nl)

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

À lire aussi

Europeans taking too long to choose negotiator for talks with Russia — Kremlin

Major central banks signal December tightening amid persistent inflation

Trading Day: Oil slump no cure for AI angst

Fastmarkets clarifies China domestic steel scrap methodology guide

Merz says Germany must preserve 'digital sovereignty' in AI era

India markets regulator backs removal of long-term capital gains tax for foreign investors, sources say

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

Partager

À lire aussi

Europeans taking too long to choose negotiator for talks with Russia — Kremlin

Major central banks signal December tightening amid persistent inflation

Trading Day: Oil slump no cure for AI angst

Fastmarkets clarifies China domestic steel scrap methodology guide

Merz says Germany must preserve 'digital sovereignty' in AI era

India markets regulator backs removal of long-term capital gains tax for foreign investors, sources say